thalidomide peg3 nh2

Thalidomide-PEG3-NH2 is a synthesized conjugate consisting of an E3 ligase ligand-linker conjugate that combines a Thalidomide-based cereblon ligand and a linker used in PROTAC technology.

Thalidomide-O-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 3) is an E3 ligase ligand-linker conjugate developed using a Thalidomide-based cereblon ligand and a 3-unit PEG linker, synthesized specifically for use in PROTAC technology.

Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, incorporates a cereblon ligand derived from Thalidomide and a 3-unit PEG linker. This compound is specifically designed for use in PROTAC technology, which utilizes small molecules to induce protein degradation [1].

Thalidomide-PEG3-NH2 hydrochloride is a Thalidomide-based cereblon ligand that recruits CRBN proteins. This compound can be connected to a target protein ligand via a linker to form a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-5-PEG3-NH2 is a synthetic E3 ligase ligand-linker conjugate that consists of a thalidomide-based cereblon ligand and a single linker.

Thalidomide-NH-amido-PEG3-C2-NH2 is a synthetic E3 ligase ligand-linker conjugate that incorporates a thalidomide-based cereblon ligand and a linker, designed for the synthesis of PROTAC.

Thalidomide-NH-amido-PEG3-C2-NH2 hydrochloride is a synthetic conjugate of an E3 ligase ligand-linker, comprising a Thalidomide-based cereblon ligand and one linker, and is utilized for synthesizing PROTAC.

Thalidomide-O-amido-C3-PEG3-C1-NH2 is a synthesized conjugate compound serving as an E3 ligase ligand-linker, featuring a cereblon ligand based on Thalidomide and a 3-unit PEG linker, specifically designed for use in PROTAC technology.

Thalidomide-Piperazine-PEG3-NH2 is a synthesized E3 ligase ligand-linker conjugate that combines a Thalidomide-based cereblon ligand with a linker commonly used in [PROTAC] technology, functioning as an E3 ligase recruiter.

Thalidomide-O-amido-PEG3-C2-NH2 TFA (Cereblon Ligand-Linker Conjugates 3 (TFA)) is a synthesized E3 ligase ligand-linker conjugate incorporating a Thalidomide-based cereblon ligand and a 3-unit PEG linker, used in PROTAC technology.

Thalidomide-5-NH-PEG3-NH2 hydrochloride is a cereblon ligand based on Thalidomide that targets CRBN proteins. It utilizes a linker to attach to a target protein ligand, facilitating the formation of a PROTAC molecule, such as THAL-SNS-032.

Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride, a synthesized E3 ligase ligand-linker conjugate, combines a Thalidomide-based cereblon ligand with a two-unit PEG linker for use in PROTAC technology[1].

Thalidomide-O-amido-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology[1].